Carcinogenesis in Lewis Rats Injected at Birth with 7,12-Dimethylbenz(a)anthracene
1963

Carcinogenesis in Lewis Rats Injected at Birth with DMBA

Sample size: 100 publication Evidence: moderate

Author Information

Author(s): B. Toth, P. Shubik

Primary Institution: Chicago Medical School, Institute of Medical Research, Division of Oncology

Hypothesis

What is the effect of DMBA when administered subcutaneously at birth in Lewis rats?

Conclusion

The study found that DMBA induces subcutaneous sarcomas in Lewis rats when injected at birth, with a clear dose-response relationship.

Supporting Evidence

  • DMBA was found to be a potent leukaemogenic agent for mice when injected at birth.
  • Subcutaneous administration of DMBA in adult rats induces mainly sarcomas.
  • Only the 1000 µg dose of DMBA significantly reduced survival rates.
  • Decreasing doses of DMBA resulted in a gradual prolongation of latent periods of induced sarcomas.
  • Two malignant lymphomas were observed in treated rats, none in controls.

Takeaway

When baby rats are given a chemical called DMBA, it can make them develop tumors, especially if they get a lot of it.

Methodology

Newborn Lewis rats were injected with varying doses of DMBA and monitored for tumor development and survival rates.

Limitations

The number of animals in some treatment groups was too small for quantitative evaluation of tumor incidence.

Participant Demographics

Lewis inbred rats, bred in the laboratory.

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication